Atlas Capital Advisors Inc. recently purchased 7,852 shares of PepsiCo, Inc., valued at approximately $1.13 million, establishing a new position during the fourth quarter. This comes as PepsiCo reported stronger-than-expected quarterly earnings and increased its dividend, despite some analysts maintaining a "Hold" rating and recent price target cuts. Institutional investors collectively own a significant 73.07% of the company's stock.

Arrowstreet Capital Limited Partnership increased its stake in eBay Inc. by 3.6% in the fourth quarter, now owning approximately 2.996 million shares valued at $261 million. This increase comes as eBay reported strong quarterly earnings with an EPS of $1.66 and revenue of $3.09 billion, exceeding analyst expectations. While the stock's consensus rating is "Hold" with an average price target of $107.84, institutional investors collectively own 87.48% of the company's stock.

Arrowstreet Capital Limited Partnership significantly increased its stake in PayPal Holdings, Inc. by 79.9% in the fourth quarter, accumulating over 3 million shares valued at approximately $178.8 million. This move is part of a broader trend of institutional investors raising their positions, with hedge funds now owning 68.32% of PayPal's stock. Despite mixed analyst ratings, PayPal reported stronger-than-expected quarterly results, and the company recently declared a dividend, reflecting continued financial activity and investor interest.

Arrowstreet Capital Limited Partnership increased its holdings in Dollar Tree, Inc. by 4.7% in the fourth quarter, acquiring an additional 81,695 shares to reach a total of 1,821,852 shares valued at $224.1 million. This increase follows Dollar Tree's better-than-expected quarterly earnings, though analyst sentiment remains mixed with a consensus "Hold" rating and an average price target of $119.48. The company's recent strong performance has led to multiple earnings forecast upgrades from Zacks Research.

Arax Advisory Partners significantly reduced its stake in Emerson Electric Co. (EMR) by 53.7% in the fourth quarter, selling 25,698 shares and retaining 22,154 shares valued at $2.94 million. Despite this reduction by one firm, institutional ownership of EMR remains high at 74.30%, with other major investors increasing their positions. The stock maintains a "Moderate Buy" consensus rating from analysts, with an average price target of $163.77, following a positive earnings report.

Arrowstreet Capital Limited Partnership reduced its stake in Dollar General Corporation (NYSE:DG) by 4.0% in the fourth quarter, selling 111,104 shares but still retaining 2.7 million shares valued at $358.6 million. Despite high institutional ownership (91.77%), analyst sentiment is largely cautious, with a consensus "Hold" rating and a target price of $131.27, even after the company surpassed EPS estimates with $2.00. Dollar General also announced a quarterly dividend of $0.59 per share.

Arrowstreet Capital Limited Partnership significantly increased its stake in Roper Technologies, acquiring an additional 237,464 shares, bringing its total to 436,487 shares valued at $194.3 million. Roper Technologies reported strong quarterly earnings of $5.16 per share on $2.10 billion in revenue, exceeding expectations. The company also declared a $0.91 quarterly dividend, although analyst ratings remain mixed with a "Hold" consensus.

Arax Advisory Partners decreased its stake in The TJX Companies, Inc. by 49.7% in Q4, selling 30,733 shares and retaining 31,085 shares valued at $4.78 million. This comes as TJX reported strong quarterly results, beating EPS and revenue estimates, with sales up 9.2% year over year. The company also announced a quarterly dividend of $0.48 per share and continues to receive positive analytical coverage.

Arax Advisory Partners significantly reduced its stake in Bristol Myers Squibb Company (NYSE:BMY) by 75.4% in the fourth quarter. Despite this, analyst sentiment remains mixed, with an average "Hold" rating and a consensus price target of $61.31. The company recently reported a Q1 earnings beat, with EPS of $1.58 and revenue of $11.49 billion, and reaffirmed its FY2026 EPS guidance.

Arrowstreet Capital Limited Partnership significantly reduced its stake in CVS Health Corporation by 18.4% in the fourth quarter, selling 974,310 shares and holding 4.32 million shares valued at $342.8 million. Despite this reduction and insider selling by executives, CVS Health shows operational momentum through expanded GLP-1 drug access, deeper AI integration, and strong financial results, surpassing revenue and EPS estimates. Analyst ratings are generally positive, with a "Moderate Buy" consensus and a price target of $100.68, while the company also announced a quarterly dividend of $0.665.